| Repurposed antiviral drugs for COVID-19—Interim WHO SOLIDARITY trial results WHO Solidarity Trial Consortium New England Journal of Medicine 384 (6), 497-511, 2021 | 2693 | 2021 |
| A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19 DR Boulware, MF Pullen, AS Bangdiwala, KA Pastick, SM Lofgren, ... New England Journal of Medicine 383 (6), 517-525, 2020 | 1590 | 2020 |
| Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial CP Skipper, KA Pastick, NW Engen, AS Bangdiwala, M Abassi, ... Annals of internal medicine 173 (8), 623-631, 2020 | 651 | 2020 |
| Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis G Butler-Laporte, A Lawandi, I Schiller, M Yao, N Dendukuri, ... JAMA internal medicine 181 (3), 353-360, 2021 | 329 | 2021 |
| Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection. EG McDonald, J Milligan, C Frenette, TC Lee JAMA: Internal Medicine 175 (5), 784-791, 2015 | 276 | 2015 |
| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses WHO Solidarity Trial Consortium The Lancet 399 (10339), 1941-1953, 2022 | 252 | 2022 |
| Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19) KA Pastick, EC Okafor, F Wang, SM Lofgren, CP Skipper, MR Nicol, ... Open Forum Infectious Diseases 7 (4), ofaa130, 2020 | 244 | 2020 |
| Hydroxychloroquine as pre-exposure prophylaxis for coronavirus disease 2019 (COVID-19) in healthcare workers: a randomized trial R Rajasingham, AS Bangdiwala, MR Nicol, CP Skipper, KA Pastick, ... Clinical Infectious Diseases 72 (11), e835-e843, 2021 | 169 | 2021 |
| Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial K Ali, T Azher, M Baqi, A Binnie, S Borgia, FM Carrier, YA Cavayas, ... CMAJ 194 (7), E242-E251, 2022 | 160* | 2022 |
| Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis AD Bai, CKL Lo, AS Komorowski, M Suresh, K Guo, A Garg, P Tandon, ... Clinical Microbiology and Infection 28 (8), 1076-1084, 2022 | 104 | 2022 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study ICC Group Infection, 1, 2021 | 103* | 2021 |
| Antibiotic Self-stewardship: Trainee-Led Structured Antibiotic Time-outs to Improve Antimicrobial Use TC Lee, C Frenette, D Jayaraman, L Green, L Pilote Annals of Internal Medicine 161 (10_Supplement), S53-S58, 2014 | 103 | 2014 |
| Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis O Del Corpo, G Butler-Laporte, DC Sheppard, MP Cheng, EG McDonald, ... Clinical Microbiology and Infection 26 (9), 1137-1143, 2020 | 91 | 2020 |
| Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-analysis TC Lee, S Vigod, É Bortolussi-Courval, R Hanula, DR Boulware, ... JAMA Network Open 5 (4), e226269-e226269, 2022 | 81* | 2022 |
| A novel method of adverse event detection can accurately identify venous thromboembolisms (VTEs) from narrative electronic health record data CM Rochefort, AD Verma, T Eguale, TC Lee, DL Buckeridge Journal of the American Medical Informatics Association 22 (1), 155-165, 2015 | 81 | 2015 |
| Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials A Amstutz, B Speich, F Mentré, CS Rueegg, D Belhadi, L Assoumou, ... The Lancet Respiratory Medicine 11 (5), 453-464, 2023 | 80 | 2023 |
| Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study S Murthy, PM Archambault, A Atique, FM Carrier, MP Cheng, C Codan, ... CMAJ open 9 (1), E181-E188, 2021 | 73 | 2021 |
| Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis TC Lee, S Murthy, O Del Corpo, J Senécal, G Butler-Laporte, ZN Sohani, ... Clinical Microbiology and Infection 28 (9), 1203-1210, 2022 | 72 | 2022 |
| Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial N Ezer, S Belga, N Daneman, A Chan, BM Smith, SA Daniels, K Moran, ... bmj 375, 2021 | 70 | 2021 |
| The MedSafer Study—Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial EG McDonald, PE Wu, B Rashidi, MG Wilson, É Bortolussi-Courval, ... JAMA Internal Medicine, 2022 | 65 | 2022 |
Emily G. McDonald MD MSCAssociate Professor of Medicine; McGill University; Scientific Director, CADEN在 mcgill.ca 的电子邮件经过验证
